NCT05518175

Brief Summary

The purpose of this study is to compare and capture key elements of the patient experience, quality of recovery, preferences and satisfaction after laparoscopic salpingectomy done via 3 different routes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
255

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 26, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

November 15, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2025

Completed
Last Updated

January 26, 2026

Status Verified

June 1, 2025

Enrollment Period

2.3 years

First QC Date

August 24, 2022

Last Update Submit

January 22, 2026

Conditions

Keywords

laparoscopyquality of recoveryvaginal natural orifice transluminal endoscopic surgery

Outcome Measures

Primary Outcomes (1)

  • Quality of recovery after surgery as assessed by the Quality of Recovery (QOR-40 )questionnaire

    This questionnaire has 40 questions, score varies from 40 (poor)-200 (excellent) a higher number indicating a better outcome

    24 hours after surgery

Secondary Outcomes (10)

  • Cosmesis as assessed by the Body Image Questionnaire

    2 weeks post surgery

  • Cosmesis as assessed by the Body Image Questionnaire

    6 weeks post surgery

  • Cosmesis as assessed by the Body Image Questionnaire

    3 months post surgery

  • Change in sexual function as assessed by the Short version of the Female Sexual Function Index (FSFI)

    Baseline, 3 months post surgery

  • Pain as assessed by the Resting Visual Analog Scale (VAS)

    24 hours post surgery

  • +5 more secondary outcomes

Study Arms (3)

Route A: Traditional laparoscopy

ACTIVE COMPARATOR
Procedure: Traditional laparoscopy

Route B: Single site laparoscopy

EXPERIMENTAL
Procedure: Single site laparoscopy

Route C:V-Notes surgery

EXPERIMENTAL
Procedure: V-Notes surgery

Interventions

Utilizes three or four ports for access and retrieval.

Route A: Traditional laparoscopy

One port is placed via a 2 to 3 cm umbilical/fascia incision. With this technique, there is a single incision, hidden in the umbilicus.

Route B: Single site laparoscopy

One port placed trans-vaginally via a 2-3 cm vaginal incision with no abdominal scars.

Route C:V-Notes surgery

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Premenopausal women scheduled to undergo an elective sterilization surgery regardless of parity
  • non-prolapsed uterus
  • Patients should able to provide written consent

You may not qualify if:

  • Women who have relative contra-indication to vaginal peritoneal access such as: history of rectal surgery, suspected recto-vaginal endometriosis based on clinical history and examination, suspected malignancy, pelvic inflammatory disease, active lower genital tract infection, virginity or pregnancy
  • Postpartum (immediate) tubal sterilization
  • Tubal sterilization during a cesarean section

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Infertility, Female

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertility

Study Officials

  • Randa J Jalloul, MD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 24, 2022

First Posted

August 26, 2022

Study Start

November 15, 2022

Primary Completion

March 7, 2025

Study Completion

June 5, 2025

Last Updated

January 26, 2026

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations